向内皮细胞能量来改善对固体瘤的CAR T细胞疗法
Gabriela E Wachholz1, Parvin Akbari1, Elisabeth J M Huijbers1
1Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Biochimica et biophysica acta. Reviews on cancer
|July 17, 2024
概括
化学抗原受体 (CAR) T细胞疗法在固体瘤中显示出前景. 将CAR T细胞与抗血管生成药物结合起来,可以克服瘤障碍,增强免疫细胞透和有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
背景情况:
- 卡尔-T细胞疗法对抗血液癌症是有效的,但在固体瘤中面临挑战.
- 固体瘤对CAR T细胞透存在障碍,包括瘤血管系统异常.
- 瘤内皮细胞对细胞因子变得不响应,阻碍免疫细胞进入.
研究的目的:
- 探索改善固体瘤中CAR T细胞治疗疗效的策略.
- 研究瘤血管和内皮细胞无能性在CAR T细胞限制中的作用.
- 评估抗血管生成疗法的潜力,以增强CAR T细胞疗法.
主要方法:
- 关于CAR T细胞治疗,瘤微环境和血管生成的当前文献的综述.
- 讨论固体瘤中内皮细胞衰退的机制.
- 分析抗血管生成药物如何恢复免疫细胞透.
主要成果:
- 瘤血管系统和内皮细胞无能阻碍CAR T细胞透到固体瘤中.
- 抗血管生成策略可能会逆转内皮细胞衰退.
- 恢复内皮细胞功能可能有助于CAR T细胞和内源性免疫细胞进入.
结论:
- 在固体瘤中,克服内皮细胞无能为成功的CAR-T细胞疗法至关重要.
- 与CAR T细胞同时使用抗血管原药是一种有前途的策略.
- 这种综合方法可以显著改善固体瘤患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K